Medicare covers prescription drugs for more than 50 million Americans, but coverage does not always mean instant access. Medicare prior authorization requires your doctor to get advance approval from your plan before it will pay for certain medications, procedures, or services. A 2024 report from the HHS Office of Inspector General found that Medicare Advantage plans denied millions of prior authorization requests annually — and that a significant share of those denials were later overturned on appeal. Knowing the rules, timelines, and appeal options puts you in a stronger position.
What Medicare Prior Authorization Covers
Prior authorization in Medicare applies across multiple parts of the program, each with its own rules:
Medicare Part D (prescription drugs): Your Part D plan — administered by a pharmacy benefit manager like Express Scripts, CVS Caremark, or OptumRx — may require prior authorization for certain covered drugs. This is the most common type of Medicare prior authorization for beneficiaries.
Medicare Advantage (Part C): Private insurance companies that offer Medicare Advantage plans can require prior authorization for medical services, procedures, specialist visits, and Part B drugs (medications administered in a clinical setting). Medicare Advantage plans have broader authority to use prior authorization than Original Medicare.
Original Medicare (Parts A and B): Original Medicare rarely requires prior authorization. However, CMS has implemented prior authorization for certain categories — including repetitive scheduled non-emergent ambulance transport, certain durable medical equipment, and some surgical procedures — where waste or abuse has been documented.
How Medicare Part D Prior Authorization Works
When your Part D plan requires prior authorization for a medication, the process follows CMS-regulated timelines:
Standard request: Your doctor submits clinical documentation to the plan. The plan must respond within 72 hours. If additional information is needed, the plan contacts your prescriber. If the plan fails to respond within 72 hours, the request is automatically approved, according to CMS regulations.
Expedited (urgent) request: If your doctor certifies that waiting the standard 72 hours could seriously jeopardize your health, the plan must respond within 24 hours. This expedited timeline applies when you are currently in the hospital, starting a new treatment for a serious condition, or when the medication is needed to prevent significant harm.
Transition supply: If you are new to a Part D plan — at the beginning of the year, when switching plans, or when transitioning from a hospital — the plan must provide a temporary supply of your current medications (at least a 30-day supply) while prior authorization is processed. This transition fill ensures you do not go without medication during the administrative process.
CMS Rule Changes Affecting Prior Authorization in 2026
The CMS Interoperability and Prior Authorization Final Rule, finalized in early 2024, introduces significant changes taking effect in 2026:
Electronic prior authorization: Medicare Advantage and Medicaid managed care plans must implement electronic PA systems using standardized Health Level 7 (HL7) FHIR APIs. This enables real-time or near-real-time processing of PA requests through provider electronic health records.
Faster decision timelines: The rule tightens decision timeframes for Medicare Advantage plans. Urgent requests must be decided within 72 hours (down from the previous standard), and standard requests within 7 calendar days.
Denial transparency: Plans must include a specific reason for any PA denial, citing the clinical criteria that were not met. This replaces vague denial language with actionable information that helps providers craft targeted appeals.
Prior authorization metrics: Plans must publicly report prior authorization approval rates, denial rates, and average decision times. This transparency allows beneficiaries to consider PA practices when choosing among plans during open enrollment.
Common Medications Requiring Medicare Prior Authorization
Not every Medicare-covered drug requires prior authorization. The medications most commonly subject to PA include:
GLP-1 receptor agonists: Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) frequently require PA due to high cost and specific clinical criteria. Plans typically require documentation of a diabetes or obesity diagnosis, failed lifestyle interventions, and specific BMI or A1C thresholds. See our Medicare Wegovy coverage guide for details.
Specialty biologics: Medications for rheumatoid arthritis, psoriasis, multiple sclerosis, and cancer almost always require PA under Part D or Part B. Plans want documentation of diagnosis, prior treatment failures, and monitoring plans.
Controlled substances: Opioids above certain quantity thresholds, benzodiazepines, and other controlled substances may require PA, particularly under CMS’s opioid safety policies.
High-cost brand-name drugs with generic alternatives: When a generic equivalent is available, many Part D plans require PA before covering the brand-name version.
How to Appeal a Medicare Prior Authorization Denial
Medicare provides a structured, multi-level appeals process. Each level adds an independent layer of review:
Level 1 — Plan redetermination: Request a redetermination from your Part D plan within 60 days of the denial. The plan must decide within 7 days (standard) or 72 hours (expedited). Submit additional clinical documentation with the appeal.
Level 2 — Independent Review Entity (IRE): If the plan upholds the denial, you can appeal to an IRE within 60 days. The IRE is an independent organization contracted by CMS. Decision timeline: 7 days standard, 72 hours expedited.
Level 3 — Office of Medicare Hearings and Appeals (OMHA): For claims meeting a minimum dollar threshold (currently $190), you can request a hearing before an Administrative Law Judge within 60 days of the IRE decision.
Levels 4 and 5: Further appeals go to the Medicare Appeals Council and, ultimately, to federal court. These levels are rarely needed for prescription drug PA disputes but are available.
According to CMS data, a meaningful percentage of Part D denials are overturned at Level 1 or Level 2. The key is submitting comprehensive clinical documentation that directly addresses the plan’s coverage criteria.
Medicare Advantage vs. Original Medicare: PA Differences
Medicare Advantage plans have significantly broader authority to use prior authorization than Original Medicare. This is a critical distinction for beneficiaries choosing between the two.
Under Original Medicare, PA is required for only a narrow set of items and services. Your doctor orders a test or prescribes a medication, and Medicare typically pays its share without pre-approval. This simplicity is one of Original Medicare’s selling points.
Medicare Advantage plans, run by private insurers, can require PA for almost any covered service — hospital admissions, imaging, specialist referrals, outpatient procedures, and Part B drugs. The HHS OIG found that some Medicare Advantage plans imposed PA requirements that inappropriately delayed or denied care. CMS has responded with stricter oversight and the new transparency requirements taking effect in 2026.
Frequently Asked Questions
Does Medicare Part B require prior authorization?
Original Medicare Part B requires prior authorization for a limited set of services, including certain durable medical equipment, repetitive ambulance transport, and specific procedures. Medicare Advantage plans may require PA for a much broader range of Part B services, including physician-administered drugs.
How long is a Medicare prior authorization valid?
Approval duration varies by plan and medication. Most Part D prior authorizations are valid for 12 months, after which a renewal request is required. Some medications, particularly controlled substances, may have shorter approval periods of 3 to 6 months.
Can my pharmacy give me an emergency supply while prior authorization is pending?
Yes. Part D plans are required to provide a temporary transition supply when you are new to a plan or when a PA is pending for a current medication. This supply is typically 30 days. Your pharmacist can process this as a transition fill. You may still owe a copay for the temporary supply.
What if my Medicare Advantage plan denies a prior authorization that Original Medicare would cover?
Medicare Advantage plans must cover everything Original Medicare covers, but they can apply utilization management tools like prior authorization. If you believe a denial is improper, appeal through the plan’s process and cite CMS rules requiring coverage parity with Original Medicare. The independent review at Level 2 is particularly important for these disputes.
Protecting Your Medicare Benefits
Medicare prior authorization does not have to be an obstacle if you approach it strategically. Have your doctor check PA requirements before prescribing. Ensure the clinical documentation is complete and specific from the first submission. Know the timelines — 72 hours for standard Part D requests, 24 hours for urgent — and hold the plan accountable if it misses them. And when a denial happens, appeal promptly with additional evidence.
For a deeper look at how PBM reform is reshaping Medicare pharmacy benefits, and how prior authorization connects to the broader policy landscape, explore our healthcare policy guide.